1877 — Shanghai Junshi Biosciences Co Cashflow Statement
0.000.00%
- HK$27.02bn
- HK$28.87bn
- CNY2.50bn
Annual cashflow statement for Shanghai Junshi Biosciences Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -1,256 | -1,452 | -1,463 | -1,459 | -1,366 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -605 | -1,776 | -2,005 | -1,434 | -520 |
| Capital Expenditures | -902 | -394 | -833 | -691 | -768 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -1,016 | -43.3 | -101 | -202 | -812 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,918 | -437 | -933 | -893 | -1,581 |
| Financing Cash Flow Items | 854 | 114 | 101 | -35.8 | 203 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2,666 | 4,613 | 712 | 1,023 | 2,229 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 120 | 2,492 | -2,219 | -1,291 | 107 |